IFNs are used as therapeutic agents for a range of disease, including hepatitis C (through its antiviral functions), some classes of cancer (through its antiproliferative and immunomodulatory functions) and multiple sclerosis (which is IFNβ specific and speculated to be related to its immunomodulatory function). This evidence concerns the gene IFNB1 and cancer.